Formononetin contributes to a decrease in Bcl-2 protein levels and an increase in Bax expression in PC-3 cells, thereby resulting in an increase in the Bax/Bcl-2 ratio and regulating the p38/Akt pathway, thereby triggering apoptosis in tumor cells. The gene discussed is BCL2; the disease is neoplasm.